{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:19Z","timestamp":1788383659283,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The study was aimed at investigating the potential role of chronic lymphocytic thyroiditis (CLT) in papillary thyroid cancer (PTC) aggressiveness for patients aged below 55, as well as to figure out factors influencing potential recurrence risk in different age groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 635 adult patients were retrospectively analyzed. 188 patients were diagnosed with coexistent CLT and the remaining 447 were classified as non-CLT. Then the characteristics of CLT-coexisted patients and non-CLT ones were compared respectively when patients were aged\u2009\u2265\u200955\u00a0years or below. The association among postoperative clinicopathological features were also analyzed using multivariate regression. In addition, the prognostic value of several variables relating to high-risk recurrence were estimated within different age groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>When divided in two age groups (55\u00a0years as the borderline), non-CLT group (aged below 55\u00a0years) had a remarkable frequency of small size lesion (D<jats:sub>max<\/jats:sub>\u2009\u2264\u20091\u00a0cm) compared with CLT-coexisted patients (54.6% to 43.0%,<jats:italic>p<\/jats:italic>\u2009=\u20090.02). In addition, non-CLT patients tended to have intrathyroidal extension as opposed to those with coexistent CLT (20.2% to 28.2%,<jats:italic>p<\/jats:italic>\u2009=\u20090.05). In multivariate analysis, CLT still significantly acted as an independent risk factor of greater lesion size (D<jats:sub>min<\/jats:sub>\u2009&gt;\u20091\u00a0cm) (OR\u2009=\u20091.7,<jats:italic>p<\/jats:italic>\u2009=\u20090.02) and mildly promoted gross extrathyroidal extension (ETE) (OR\u2009=\u20091.4,<jats:italic>p<\/jats:italic>\u2009=\u20090.06). However, associations didn\u2019t emerge in the characteristics mentioned above with CLT when patients were\u2009\u2265\u200955\u00a0years old. The prognostic value of CLT in high-risk recurrence was evident only in patients aged 35\u201344\u00a0years. (OR\u2009=\u20092.4, 95%CI:1.2\u20135.4,<jats:italic>p<\/jats:italic>\u2009=\u20090.02). Greater lesion size independently promoted gross ETE, no matter patients were aged above 55\u00a0years or not. Its prognostic value of high-risk recurrence was significant throughout all age groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings revealed that CLT coexistence might be the unfavorable factor of PTC aggressiveness in patients aged below 55\u00a0years. Its role as well as greater tumor size may potentially predict higher recurrence risk according to results figured out in the prediction model.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12902-022-00945-4","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T10:06:57Z","timestamp":1646647617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Bing\u2019e","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-1177","authenticated-orcid":false,"given":"Chaoqun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"4","key":"945_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jnci\/djx227","volume":"110","author":"Y Huang","year":"2018","unstructured":"Huang Y, Qu S, Zhu G, Wang F, Liu R, Shen X, et al. BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment. JNCI: Journal of the National Cancer Institute. 2018;110(4):362\u201370.","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"2","key":"945_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12011-017-1209-6","volume":"184","author":"H Zhao","year":"2018","unstructured":"Zhao H, Li H, Huang T. High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk. Biol Trace Elem Res. 2018;184(2):317\u201324.","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"945_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/hed.26577","volume":"43","author":"B LaBarge","year":"2020","unstructured":"LaBarge B, Walter V, Bann DV, Goldenberg D. In-depth analysis of thyroid cancer mortality. Head Neck. 2020;43(3):977.","journal-title":"Head Neck"},{"issue":"3","key":"945_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1507\/endocrj.EJ17-0026","volume":"64","author":"T Takano","year":"2017","unstructured":"Takano T. Natural history of thyroid cancer [Review]. Endocr J. 2017;64(3):237\u201344.","journal-title":"Endocr J"},{"issue":"2","key":"945_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13304-017-0449-5","volume":"69","author":"P Miccoli","year":"2017","unstructured":"Miccoli P, Bakkar S. Surgical management of papillary thyroid carcinoma: an overview. Updat Surg. 2017;69(2):145\u201350.","journal-title":"Updat Surg"},{"issue":"3","key":"945_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/PAP.0b013e3182534868","volume":"19","author":"R Ahmed","year":"2012","unstructured":"Ahmed R, Al-Shaikh S, Akhtar M. Hashimoto thyroiditis: a century later. Adv Anat Pathol. 2012;19(3):181\u20136.","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"945_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","volume":"70","author":"ME Dailey","year":"1955","unstructured":"Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955;70(2):291\u20137.","journal-title":"AMA Arch Surg"},{"issue":"1","key":"945_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12020-017-1401-7","volume":"58","author":"C-T Shen","year":"2017","unstructured":"Shen C-T, Zhang X-Y, Qiu Z-L, Sun Z-K, Wei W-J, Song H-J, et al. Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword? Endocrine. 2017;58(1):176\u201383.","journal-title":"Endocrine"},{"issue":"6","key":"945_CR9","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1210\/jc.2013-1309","volume":"98","author":"S Dvorkin","year":"2013","unstructured":"Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab. 2013;98(6):2409\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"945_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10147-014-0754-7","volume":"20","author":"HY Kwak","year":"2015","unstructured":"Kwak HY, Chae BJ, Eom YH, Hong YR, Seo JB, Lee SH, et al. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol. 2015;20(3):463\u201373.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"945_CR11","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ijc.31944","volume":"144","author":"E Song","year":"2019","unstructured":"Song E, Oh H-S, Jeon MJ, Chung KW, Hong SJ, Ryu JS, et al. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma. Int J Cancer. 2019;144(6):1414\u201320.","journal-title":"Int J Cancer"},{"issue":"3","key":"945_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/0194599812472426","volume":"148","author":"Y Lun","year":"2013","unstructured":"Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, et al. Hashimoto\u2019s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg. 2013;148(3):396\u2013402.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"945_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jss.2007.09.020","volume":"150","author":"D Repplinger","year":"2008","unstructured":"Repplinger D, Bargren A, Zhang Y-W, Adler JT, Haymart M, Chen H. Is Hashimoto\u2019s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150(1):49\u201352.","journal-title":"J Surg Res"},{"issue":"5","key":"945_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s002680020165","volume":"25","author":"E Kebebew","year":"2001","unstructured":"Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001;25(5):632\u20137.","journal-title":"World J Surg"},{"issue":"3","key":"945_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12022-011-9164-9","volume":"22","author":"B-Y Huang","year":"2011","unstructured":"Huang B-Y, Hseuh C, Chao T-C, Lin K-J, Lin J-D. Well-differentiated thyroid carcinoma with concomitant Hashimoto\u2019s thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol. 2011;22(3):144\u20139.","journal-title":"Endocr Pathol"},{"issue":"9","key":"945_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/ERC-17-0085","volume":"24","author":"V Marotta","year":"2017","unstructured":"Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, et al. Hashimoto\u2019s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer. Endocr Relat Cancer. 2017;24(9):485\u201393.","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"945_CR17","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1158\/0008-5472.CAN-10-3844","volume":"71","author":"C Nucera","year":"2011","unstructured":"Nucera C, Lawler J, Parangi S. BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression. Cancer Res. 2011;71(7):2417\u201322.","journal-title":"Cancer Res"},{"issue":"23","key":"945_CR18","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.1073\/pnas.1004934107","volume":"107","author":"C Nucera","year":"2010","unstructured":"Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, et al. B-RafV600E and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci. 2010;107(23):10649\u201354.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"945_CR19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.12194","volume":"79","author":"V Marotta","year":"2013","unstructured":"Marotta V, Guerra A, Zatelli MC, Uberti ED, Di Stasi V, Faggiano A, et al. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto\u2019s thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf). 2013;79(5):733\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"945_CR20","first-page":"1","volume":"33","author":"P Del Rio","year":"2008","unstructured":"Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol. 2008;33(1):1\u20135.","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"945_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00423-012-1021-x","volume":"398","author":"A Konturek","year":"2013","unstructured":"Konturek A, Barczy\u0144ski M, Wierzchowski W, Stopa M, Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg. 2013;398(3):389\u201394.","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"945_CR22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00268-012-1423-5","volume":"36","author":"Y Ito","year":"2012","unstructured":"Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg. 2012;36(6):1274\u20138.","journal-title":"World J Surg"},{"issue":"4","key":"945_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/archsurg.133.4.419","volume":"133","author":"LE Sanders","year":"1998","unstructured":"Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg. 1998;133(4):419\u201325.","journal-title":"Arch Surg"},{"issue":"3","key":"945_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.1998.8.197","volume":"8","author":"K Kashima","year":"1998","unstructured":"Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 1998;8(3):197\u2013202.","journal-title":"Thyroid"},{"issue":"2","key":"945_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","volume":"84","author":"KC Loh","year":"1999","unstructured":"Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism. 1999;84(2):458.","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"8","key":"945_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","volume":"27","author":"JS Jeong","year":"2012","unstructured":"Jeong JS, Kim HK, Lee C-R, Park S, Park JH, Kang S-W, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci. 2012;27(8):883\u20139.","journal-title":"J Korean Med Sci"},{"issue":"12","key":"945_CR27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"RM Tuttle","year":"2010","unstructured":"Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20(12):1341\u20139.","journal-title":"Thyroid"},{"issue":"3","key":"945_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1530\/EJE-11-0466","volume":"165","author":"MG Castagna","year":"2011","unstructured":"Castagna MG, Maino F, Cipri C, Belardini V, Theodoropoulou A, Cevenini G, et al. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol. 2011;165(3):441\u20136.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"945_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EJE-13-0524","volume":"170","author":"MJ Jeon","year":"2014","unstructured":"Jeon MJ, Kim WG, Park WR, Han JM, Kim TY, Song DE, et al. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma. Eur J Endocrinol. 2014;170(1):23\u201330.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"945_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cncr.30360","volume":"123","author":"BR Haugen","year":"2017","unstructured":"Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? Cancer. 2017;123(3):372\u201381.","journal-title":"Cancer"},{"issue":"2","key":"945_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000486367","volume":"7","author":"S Babli","year":"2018","unstructured":"Babli S, Payne RJ, Mitmaker E, Rivera J. Effects of Chronic Lymphocytic Thyroiditis on the Clinicopathological Features of Papillary Thyroid Cancer. Eur Thyroid J. 2018;7(2):95\u2013101.","journal-title":"Eur Thyroid J"},{"issue":"4","key":"945_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/coa.12520","volume":"41","author":"HY Nam","year":"2016","unstructured":"Nam HY, Lee HY, Park GC. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study. Clin Otolaryngol. 2016;41(4):358\u201364.","journal-title":"Clin Otolaryngol"},{"issue":"1","key":"945_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/ERC-15-0408","volume":"23","author":"SK Kim","year":"2016","unstructured":"Kim SK, Woo J-W, Lee JH, Park I, Choe J-H, Kim J-H, et al. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23(1):27\u201334.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"945_CR34","first-page":"1050","volume":"114","author":"ID Hay","year":"1993","unstructured":"Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050\u20137.","journal-title":"Surgery"},{"issue":"1","key":"945_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jcem-19-1-162","volume":"19","author":"DW Meier","year":"1959","unstructured":"Meier DW, Woolner LB, Beahrs OH, McConahey WM. Parenchymal findings in thyroidal carcinoma: pathologic study of 256 cases. J Clin Endocrinol Metab. 1959;19(1):162\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"945_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/EJE-12-0903","volume":"168","author":"J-H Lee","year":"2013","unstructured":"Lee J-H, Kim Y, Choi J-W, Kim Y-S. The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168(3):343\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"945_CR37","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/000313480507101018","volume":"71","author":"C Cipolla","year":"2005","unstructured":"Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg. 2005;71(10):874\u20138.","journal-title":"Am Surg"},{"key":"945_CR38","unstructured":"Matesa-Ani\u0107 D, Matesa N, Dabeli\u0107 N, Kusi\u0107 Z. Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta Clin Croat. 2009;48(1)."},{"issue":"3","key":"945_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/thy.1994.4.351","volume":"4","author":"LE Braverman","year":"1994","unstructured":"Braverman LE. Iodine and the thyroid: 33 years of study. Thyroid. 1994;4(3):351\u20136.","journal-title":"Thyroid"},{"issue":"5","key":"945_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.14639\/0392-100X-1709","volume":"37","author":"J Liang","year":"2017","unstructured":"Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, et al. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients. Acta Otorhinolaryngol Ital. 2017;37(5):393\u2013400.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"10","key":"945_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3727\/096504009789735431","volume":"17","author":"A Antonaci","year":"2009","unstructured":"Antonaci A, Consorti F, Mardente S, Giovannone G. Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncol Res. 2009;17(10):495\u2013503.","journal-title":"Oncol Res"},{"issue":"3","key":"945_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/cen.13032","volume":"85","author":"TP de Castro","year":"2016","unstructured":"de Castro TP, Waissmann W, Sim\u00f5es TC, de Mello RCR, Carvalho DP. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study. Clin Endocrinol. 2016;85(3):466\u201374.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"945_CR43","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00268-019-05337-9","volume":"44","author":"I Lee","year":"2020","unstructured":"Lee I, Kim HK, Soh EY, Lee J. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer. World J Surg. 2020;44(5):1506\u201313.","journal-title":"World J Surg"},{"issue":"6","key":"945_CR44","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jso.25683","volume":"120","author":"E Abraham","year":"2019","unstructured":"Abraham E, Roshan D, Tran B, Wykes J, Campbell P, Ebrahimi A. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer. J Surg Oncol. 2019;120(6):1016\u201322.","journal-title":"J Surg Oncol"},{"issue":"17","key":"945_CR45","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-11-1316","volume":"71","author":"WH Fridman","year":"2011","unstructured":"Fridman WH, Galon J, Pag\u00e8s F, Tartour E, Saut\u00e8s-Fridman C, Kroemer G. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res. 2011;71(17):5601\u20135.","journal-title":"Cancer Res"},{"issue":"9","key":"945_CR46","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/1097-0142(19881101)62:9<1988::AID-CNCR2820620919>3.0.CO;2-0","volume":"62","author":"H Kamma","year":"1988","unstructured":"Kamma H, Fujii K, Ogata T. Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer. 1988;62(9):1988\u201393.","journal-title":"Cancer"},{"issue":"2","key":"945_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.canlet.2008.03.060","volume":"267","author":"MG Borrello","year":"2008","unstructured":"Borrello MG, Degl\u2019Innocenti D, Pierotti MA. Inflammation and cancer: the oncogene-driven connection. Cancer Lett. 2008;267(2):262\u201370.","journal-title":"Cancer Lett"},{"issue":"2","key":"945_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1677\/erc.1.00947","volume":"12","author":"E Puxeddu","year":"2005","unstructured":"Puxeddu E, Knauf JA, Sartor MA, Mitsutake N, Smith EP, Medvedovic M, et al. RET\/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. Endocr Relat Cancer. 2005;12(2):319\u201334.","journal-title":"Endocr Relat Cancer"},{"issue":"41","key":"945_CR49","doi-asserted-by":"publisher","first-page":"14825","DOI":"10.1073\/pnas.0503039102","volume":"102","author":"MG Borrello","year":"2005","unstructured":"Borrello MG, Alberti L, Fischer A, Degl\u2019innocenti D, Ferrario C, Gariboldi M, et al. Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene. Proc Natl Acad Sci U S A. 2005;102(41):14825\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"945_CR50","doi-asserted-by":"publisher","first-page":"52131","DOI":"10.1074\/jbc.M306003200","volume":"278","author":"E Puxeddu","year":"2003","unstructured":"Puxeddu E, Mitsutake N, Knauf JA, Moretti S, Kim HW, Seta KA, et al. Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET\/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway. J Biol Chem. 2003;278(52):52131\u20138.","journal-title":"J Biol Chem"},{"issue":"35","key":"945_CR51","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/sj.onc.1207790","volume":"23","author":"MD Castellone","year":"2004","unstructured":"Castellone MD, Guarino V, De Falco V, Carlomagno F, Basolo F, Faviana P, et al. Functional expression of the CXCR4 chemokine receptor is induced by RET\/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene. 2004;23(35):5958\u201367.","journal-title":"Oncogene"},{"issue":"4","key":"945_CR52","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI87345","volume":"126","author":"RM Melillo","year":"2016","unstructured":"Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, et al. The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest. 2016;126(4):1603.","journal-title":"J Clin Invest"},{"issue":"3","key":"945_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/jcp.2003.008474","volume":"57","author":"SL Asa","year":"2004","unstructured":"Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004;57(3):225\u201332.","journal-title":"J Clin Pathol"},{"issue":"5302","key":"945_CR54","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.275.5302.960","volume":"275","author":"C Giordano","year":"1997","unstructured":"Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto\u2019s thyroiditis. Science (New York, NY). 1997;275(5302):960\u20133.","journal-title":"Science (New York, NY)"},{"issue":"12","key":"945_CR55","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","volume":"25","author":"M Ehlers","year":"2014","unstructured":"Ehlers M, Schott M. Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab. 2014;25(12):656\u201364.","journal-title":"Trends Endocrinol Metab"},{"key":"945_CR56","doi-asserted-by":"publisher","first-page":"149185","DOI":"10.1155\/2014\/149185","volume":"2014","author":"G Landskron","year":"2014","unstructured":"Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.","journal-title":"J Immunol Res"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-00945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T13:43:07Z","timestamp":1700314987000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-00945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-00945-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"22 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China and the study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines (IRB number: 2019LWKY006). All patients have given informed consent before surgery and they agreed with the requirement for their individual clinical data involved in our research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}